elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q59138094-315C1803-A6A0-4DB1-9DBF-B8D3A4F893D7
Q59138094-315C1803-A6A0-4DB1-9DBF-B8D3A4F893D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59138094-315C1803-A6A0-4DB1-9DBF-B8D3A4F893D7
Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target
P2860
Q59138094-315C1803-A6A0-4DB1-9DBF-B8D3A4F893D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59138094-315C1803-A6A0-4DB1-9DBF-B8D3A4F893D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6674c7192818393d59ded6798c7248d92118b5a3
P2860
Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT1A receptor in the treatment of major depressive disorder.